139 related articles for article (PubMed ID: 271033)
1. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
Craft AW; Kay H; Lawson DN; McElwain TJ
Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
[TBL] [Abstract][Full Text] [Related]
2. Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?
Dagdemir A; Yildirim H; Aliyazicioglu Y; Kanber Y; Albayrak D; Acar S
Support Care Cancer; 2004 Apr; 12(4):263-7. PubMed ID: 14767751
[TBL] [Abstract][Full Text] [Related]
3. Enteropathy complicating maintenance therapy in acute lymphoblastic leukaemia.
Lewis IJ; Mainwaring D; Martin J
Arch Dis Child; 1982 Sep; 57(9):663-7. PubMed ID: 6982027
[TBL] [Abstract][Full Text] [Related]
4. [Malabsorption syndrome in the course of treatment with cytostatics of a child in remission from acute leukemia].
Ciepielewska D; Ochocka M; Kłos J
Pediatr Pol; 1979 Sep; 54(9):1059-63. PubMed ID: 291891
[No Abstract] [Full Text] [Related]
5. Jejunal crypt cell abnormalities associated with methotrexate treatment in children with acute lymphoblastic leukaemia.
Pinkerton CR; Cameron CH; Sloan JM; Glasgow JF; Gwevava NJ
J Clin Pathol; 1982 Nov; 35(11):1272-7. PubMed ID: 6958682
[TBL] [Abstract][Full Text] [Related]
6. Enterotoxic effect of methotrexate: does it influence the drug's absorption in children with acute lymphoblastic leukaemia?
Pinkerton CR; Glasgow JF; Bridges JM; Welshman SG
Br Med J (Clin Res Ed); 1981 Apr; 282(6272):1276-7. PubMed ID: 6784815
[No Abstract] [Full Text] [Related]
7. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood.
Gwavava NJ; Pinkerton CR; Glasgow JF; Sloan JM; Bridges JM
J Clin Pathol; 1981 Jul; 34(7):790-5. PubMed ID: 6943149
[TBL] [Abstract][Full Text] [Related]
8. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
9. Small bowel function in acute lymphoblastic leukaemia.
Pearson AD; Craft AW; Pledger JV; Eastham EJ; Laker MF; Pearson GL
Arch Dis Child; 1984 May; 59(5):460-5. PubMed ID: 6428327
[TBL] [Abstract][Full Text] [Related]
10. Absorption of methotrexate under standardized conditions in children with acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Dempsey SI; Bridges JM; Glasgow JF
Br J Cancer; 1980 Oct; 42(4):613-5. PubMed ID: 6934003
[No Abstract] [Full Text] [Related]
11. Analysis of treatment in childhood leukaemia. I. Predisposition to methotrexate-induced neutropenia after craniospinal irradiation. Report to the Medical Research Council of the Working Party on Leukaemia in Childhood.
Br Med J; 1975 Sep; 3(5983):563-6. PubMed ID: 1100179
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute lymphoblastic leukaemia. Comparison of immunotherapy (B.C.G.), intermittent methotrexate, and no therapy after a five-month intensive cytotoxic regimen ((Concord trial). Preliminary report to the Medical Research Council by the Leukaemia Committee and the Working Party on Leukaemia in Childhood.
Br Med J; 1971 Oct; 4(5781):189-94. PubMed ID: 4940157
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate absorption in children with acute lymphoblastic leukemia.
Craft AW; Rankin A; Aherne W
Cancer Treat Rep; 1981; 65 Suppl 1():77-81. PubMed ID: 6948609
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate hepatotoxicity in children with leukemia.
McIntosh S; Davidson DL; O'Brien RT; Pearson HA
J Pediatr; 1977 Jun; 90(6):1019-21. PubMed ID: 870655
[TBL] [Abstract][Full Text] [Related]
15. Methotrexate infusions in poor prognosis acute lymphoblastic leukemia in children: I. The Norwegian methotrexate study in acute lymphoblastic leukemia in childhood, August 1975-December 1980.
Moe PJ; Seip M; Finne PH; Kolmannskog S
Med Pediatr Oncol; 1986; 14(3):187-8. PubMed ID: 3462465
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of daunorubicin (NSC-82151) and methotrexate (NSC-740) in combination as a remission maintenance regimen in the treatment of acute leukemia.
Humphrey B; Fernbach DJ; Razek AA; Stuckey WJ; Komp D; George S
Cancer Chemother Rep; 1975; 59(2 Pt 1):395-9. PubMed ID: 1097097
[TBL] [Abstract][Full Text] [Related]
17. Modification of oral methotrexate absorption in children with leukemia.
Mahony MJ; Murphy MS; Wadsworth J; Mott MG
Cancer Chemother Pharmacol; 1984; 12(2):131-3. PubMed ID: 6583027
[TBL] [Abstract][Full Text] [Related]
18. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia.
Kearney PJ; Light PA; Preece A; Mott MG
Cancer Chemother Pharmacol; 1979; 3(2):117-20. PubMed ID: 292536
[TBL] [Abstract][Full Text] [Related]
19. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?
Pinkerton CR; Welshman SG; Glasgow JF; Bridges JM
Lancet; 1980 Nov; 2(8201):944-6. PubMed ID: 6107590
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral and intramuscular methotrexate in children with acute lymphoblastic leukaemia.
Pearson AD; Mills S; Amineddine HA; Long DR; Craft AW; Chessells JM
Cancer Chemother Pharmacol; 1987; 20(3):243-7. PubMed ID: 3315283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
